IBA and Shreeji Expand PET Radiopharmaceutical Manufacturing with €5–7M Cyclotron Deal
Event summary
- IBA and Shreeji signed a multi-site agreement for four Cyclone® KIUBE 300 cyclotrons, valued at €5–7 million.
- The cyclotrons will be deployed in Ahmedabad, Nagpur, Kochi, and Bhubaneswar to support PET radiopharmaceutical manufacturing.
- Shreeji will add the cyclotrons to its existing network, boosting domestic production and supply-chain resilience.
- The deal strengthens IBA’s presence in India and supports its mission to broaden access to PET diagnostics in cancer care.
The big picture
The deal underscores the rapid growth of India’s PET imaging market, with increasing pressure on secure tracer supply as access extends beyond major cities. By deploying mid-energy cyclotrons, Shreeji aims to reduce logistics risk and create additional capacity for new tracers, while IBA strengthens its foothold in the region. This partnership aligns with broader trends in nuclear medicine, emphasizing local manufacturing and reliable supply chains to support cancer care.
What we're watching
- Market Expansion
- How the deployment of cyclotrons in new Indian cities will stimulate latent PET demand and improve patient access.
- Operational Efficiency
- Whether the Cyclone® KIUBE’s efficiency will contain operating costs across multiple sites and support scalable growth.
- Strategic Partnerships
- The pace at which IBA and Shreeji can introduce next-generation tracers and enhance patient care through this collaboration.